(Q50925648)

25 March 2018

title

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial. (English)

1 reference

25 March 2018

0 references

1 reference

1 reference

2

Maree Teesson

1 reference

25 March 2018

Kirsten C Morley

1

1 reference

25 March 2018

Sophie C Reid

3

1 reference

25 March 2018

Claudia Sannibale

4

1 reference

25 March 2018

Clare Thomson

5

1 reference

25 March 2018

Nghi Phung

6

1 reference

25 March 2018

Martin Weltman

7

1 reference

25 March 2018

James R Bell

8

1 reference

25 March 2018

Kylie Richardson

9

1 reference

25 March 2018

Paul S Haber

10

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 October 2006

1 reference

25 March 2018

published in

Addiction

1 reference

25 March 2018

volume

101

1 reference

25 March 2018

page(s)

1451-1462

1 reference

25 March 2018

issue

10

1 reference

25 March 2018

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Naltrexone-induced alterations in human ethanol intoxication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

A three-pathway psychobiological model of craving for alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Psychometric properties of the Penn Alcohol Craving Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Comparison of the Alcohol Dependence Scale and diagnostic interview schedule in homeless women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Psychometric analyses of the Alcohol Dependence Scale among United States and Russian clinical samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.2006.01555.X

10.1111/J.1360-0443.2006.01555.X

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

16968347

1 reference

25 March 2018